Pfizer (PFE) Exchange Rate Effect (2009 - 2026)

Pfizer (PFE) has reported Exchange Rate Effect for 18 consecutive years, with -$4.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Exchange Rate Effect fell 109.76% year-over-year to -$4.0 million in Q2 2026; TTM through Jun 2026 was $22.0 million, a 204.76% increase from a year earlier, with the FY2025 full-year figure at $41.0 million, up 162.12% from the prior year.
• Exchange Rate Effect was -$4.0 million for Q2 2026 at Pfizer, down from $19.0 million in the prior quarter.
• Over five years, Exchange Rate Effect peaked at $41.0 million in Q2 2025 and troughed at -$66.0 million in Q3 2022.
• A 5-year average of -$7.3 million and a median of -$3.0 million in 2023 frame the typical range for Exchange Rate Effect.
• Across the five-year window, Exchange Rate Effect sank 1420.0% in 2022 and soared 371.43% in 2026, its largest moves.
• Over 5 years, Exchange Rate Effect stood at -$66.0 million in 2022, then surged by 98.48% to -$1.0 million in 2023, then slumped by 3600.0% to -$37.0 million in 2024, then surged by 113.51% to $5.0 million in 2025, then sank by 180.0% to -$4.0 million in 2026.
• The last three Exchange Rate Effect figures came in at -$4.0 million (Q2 2026), $19.0 million (Q1 2026), and $5.0 million (Q4 2025), per Business Quant data.